Moneycontrol PRO

HomeNewsTrendsIt

Trending Topics

Nikhil Kamath Shashi Tharoor Elon Musk Sam Altman Kristin Cabot

It

Jump to Category

Indian IT should take a leaf from Accenture’s M&A strategy

Accenture is using acquisitions to quickly scale-up in new growth areas
Data Story: A revamped Cognizant is upping the ante for Indian IT

Cognizant has won more mega deals compared to Indian IT peers so far this year
Chart of the Day: Employee attrition was ticking up at TCS even before the current wave of layoffs

Attrition also increased at Infosys in the last one year
Cyient Q1 FY26: Misses the mark again

Macro improves late in quarter, but recovery across segments remains uneven
Advertisement
Remove Ad
Advertisement
Remove Ad
Advertisement
Remove Ad
Advertisement
Remove Ad
Chart of the Day | Low vacancies power investments in data centres

The recent surge in AI workload is likely to bring in transformational changes to demand contours
LTTS Q1 FY26: What to expect from the stock after muted quarterly numbers?

Q1 miss driven by insipid demand and pressure in the mobility segment
HCL Tech Q1 FY26: Short-term pain for long-term gain

Margins took a hit because of the company’s investments for the future
TCS Q1 FY26 – Is it a long-term add despite the quarterly disappointment?

The current financial year is likely to be similar to FY25 despite assumptions of a back-ended recovery
Advertisement
Remove Ad
All India IT employee union oppose TCS’ capped bench time, 225 days billability policy

The new associate deployment policy of TCS puts the onus of finding projects on the employees instead of the Resource Management Group (RMG) assigning them work, the IT employee union said.
LTTS: Muted results in Q4, recovery building this fiscal

Execution softness offset by strong deal wins and stable outlook
UK FTA can help Indian IT manage costs better, but no immediate earnings boost

The free trade agreement (FTA) does not propose changes to visas or immigration policies
Why this growth leader from Indian IT is a must add

Revenue traction, sequential margin improvement, and record order flows set the stage for earnings growth
Advertisement
Remove Ad
Mphasis: Strong quarter, cautious outlook

Strategic deals and steady growth in uncertain times
KPIT posts steady performance in Q4, leveraging resilient execution

The commentary for H1 FY26 is cautious amid macro challenges

Can this IT company rebound in FY26 after a tough FY25?

Leadership transition and sustainability segment’s setbacks weigh on the company’s outlook
Data Story: How growth outlook for IT companies deteriorated from February 2025

IT spending came under increased scrutiny as tariff-related economic uncertainty intensified
Advertisement
Remove Ad
TCS Q4 FY25 – Is it worth a look post the U-turn on US tariff?

Upside triggers are missing, but downside looks limited despite volatility
Indian IT stocks – value buy or a value trap?

Market volatility is likely to be the order of the day in the near term
Can this IT firm maintain growth momentum in a challenging demand environment?

Mphasis reported a subdued performance in Q3FY25, primarily because of seasonality and cross-currency headwinds.
Chart of the Day | India’s Digital Boom: What’s powering the rise of data centres?

The rapid rise in India’s digital consumption is propelling an unprecedented demand for data centres. But how sustainable is this growth?
Advertisement
Remove Ad
Chart of the Day | How Trump’s tariffs are changing IT companies’ demand outlook

Tariffs are not expected to uniformly affect all business segments of IT companies
How to deal with Indian IT stocks after Accenture’s cautious commentary?

Though the company’s business performance was steady in Q2FY25, it called out specific areas of uncertainty
KPIT: Steady show riding on new technologies, but macro overhang remains

The company expands client base and deal pipeline, maintains positive growth outlook for FY2025.
Chart of the Day: IT stock valuations still out of sync with revenue growth rates

The current revenue estimates indicate notably slower growth in FY25 and FY26 compared to pre-COVID years
Advertisement
Remove Ad
IKS Health: Can this stock restore your portfolio’s health?

IKS Health is an opportunity to participate in the US healthcare outsourcing market that is growing at a steady pace and is still relatively under-penetrated

« First «1 2 3 4 5 6 7 8 9 10 »Last »

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347